The largest database of trusted experimental protocols

44 protocols using l nna

1

Investigating ACh Response with CAT Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the effect of CAT inhibitors on the acetylcholine response in human IMA, ring segments were divided into three groups and incubated with Krebs solution containing the NO synthase inhibitor, NG-nitro-L-arginine (L-NNA, 100 µmol/L; Sigma-Aldrich) plus the cyclooxygenase inhibitor, indomethacin (10 µmol/L) (control); L-NNA plus indomethacin plus the CAT inhibitor, aminooxyacetic acid (AOAA, 100µmol/L; Sigma-Aldrich); or L-NNA plus indomethacin plus a competitive CAT substrate, L-aspartate (1000 µmol/L; Sigma-Aldrich). After equilibration for 45 min in the organ chamber, ring segments were pre-contracted with –8 log M of U-46619. Acetylcholine (−10 to −4.5 log M)-induced relaxation curves were then established.
+ Open protocol
+ Expand
2

Angiotensin-(1-7) Alleviates Stress-Induced Gastric Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were randomly divided into the following groups (8 rats each):
1) Control group (C); in which rats received no treatment and were left freely wandering in their cages for 3 hours after being subjected to pyloric ligation.
2) CRS group; in which rats received no treatment before exposure to CRS.
3) Stressed Ang-(1-7) treated group; in which rats were treated by Ang-(1-7) (6.5 mg/kg, i.p) (Sigma, USA) (11) one hour before exposure to CRS.
4) Stressed L-NNA-Ang-(1-7) treated group; in which the rats were treated by Ang-(1-7) (6.5 mg/kg, i.p.) thirty minutes after being treated by L-NNA (20 mg/kg, i.p) (Sigma, USA) (12) and after another thirty minutes rats were exposed to CRS.
5) Stressed Indo-Ang-(1-7) treated group; in which the rats were treated by Ang-(1-7) (6.5 mg/kg, i.p) thirty minutes after being treated by indomethacin (5 mg/kg /i.p) (Sigma, USA) (13) and after another thirty minutes rats were exposed to CRS.
Three hours after pyloric ligation, the rats were anesthetized by light ether anaesthesia, and blood samples were taken from the jugular vein. Then their stomachs were removed, opened along the greater curvature and the gastric content of each stomach was collected. The stomachs were washed with ice-cold saline and examined for gross gastric mucosal lesions using a magnifi ed lens by an observer not aware of the experiment.
+ Open protocol
+ Expand
3

Vasoactive Agents Pharmacology Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
The drugs used in this study were: PA (PHL83553, Sigma, USA), indomethacin (PHR1247, Sigma, USA), L-phenylephrine chloride (PE) (PHR1017, Sigma, USA), acetylcholine chloride (A2662, Sigma, USA), L-NAME (N5752, Sigma, USA), L-NG-nitroarginine (L-NNA) (N5501, Sigma, USA), 1 H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (495,320, Sigma, USA). Indomethacin was dissolved in 0.1 M Na2CO3 solution. ODQ and PA were prepared in 20% dimethyl sulfoxide (DMSO). Others were dissolved in distilled water. The final concentration of DMSO in the bath was less than 0.5%, which had no influence on vasodilatation [12 (link)].
+ Open protocol
+ Expand
4

Perfusion Methodology for Tissue Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues used for imaging and electrophysiological experiments were perfused with KRB solution containing (mM): NaCl, 120.35; KCl, 5.9; NaHCO3, 15.5; NaH2PO4, 1.2; MgCl2, 1.2; CaCl2, 2.5; and glucose, 11.5. KRB solution was oxygenated with a mixture of 97% O2/3% CO2 and warmed to 37°C. For experiments using 0 mM [Ca2+]o, CaCl2 was excluded from the KRB solution and 0.5 mM EGTA was added, resulting in a Ca2+ free KRB solution. Ca2+ free Hanks’ solution contained the following (mM): NaCl, 125; KCl, 5.36; Glucose, 10; Sucrose, 2.9; NaHCO3, 15.5; KH2PO4, 0.44; Na2HPO4, 0.33; Hepes, 10. The pH was adjusted to 7.4 with NaOH.
Nifedipine, nicardipine, atropine, guanethidine, L-NNA, CPA, tetracaine, caffeine, EGTA, and GSK 7975A were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ani9 and MRS2500 was purchased from Tocris Bioscience (Ellisville, Missouri, USA). TTX was purchased from Abcam (Cambridge, MA, USA). Atropine, guanethidine, L-NNA, MRS2500, TTX, CPA, tetracaine and caffeine were diluted in deionized water. Nifedipine and nicardipine were diluted in ethanol. Ani9 was diluted in DMSO. All stock solutions of drugs were diluted to the desired final concentrations with KRB solution.
+ Open protocol
+ Expand
5

Comprehensive Pharmacological Reagents Catalog

Check if the same lab product or an alternative is used in the 5 most similar protocols
TTX, NBQX, D-AP5, S-MCPG, MRS2179 and A967079 were obtained from Tocris Biosciences; U46619, NF449, L-161982, U73122, CAY10441, PPOH, MAFP and FIPI from Cayman Chemicals; NS-398 and SC-560 from Calbiochem-Merck Millipore; RHC-80267 from Enzo Life Science; VU0155069 and CAY10594 from Santa Cruz; L-NNA, α,β-methylene ATP, NF023 and PGE2 from Sigma; Alexa Fluor 488, Alexa Fluor 594, Fluo-4 pentapotassium salt, BAPTA tetrapotassium salt and Alexa Fluor 488 or FITC conjugated IB4 from Life Technologies; and PBS and Alexa Fluor 633 hydrazide from Thermo Scientific. All other salts and reagents were purchased from Sigma.
+ Open protocol
+ Expand
6

Pharmacological Tools for Vascular Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mtx, ACh, tempol, L-NNA and indomethacin were purchased from Sigma-Aldrich (Tres Cantos, Madrid, Spain). SQ 29548 was obtained from Cayman Chemical Co. (Ann Harbor, MI).
+ Open protocol
+ Expand
7

Mesenteric Vascular Function Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mesenteric bed was immediately removed after animal sacrifice, and isolated mesenteric vessels with an average internal diameter of 250 μm were dissected and prepared as segments with intact PVAT and segments without PVAT. The vessels were studied using a multi-wire myograph system (Model 610 M, version 2.2; Danish Myo Technology) and analysed with ADInstruments Chart™ 5 (version 5.5.1). The vessels were bathed in physiologic saline solution (PSS; as above), maintained at 37°C and gassed with a mixture of 95% air and 5% CO2. The vessels were normalised and their viability was checked by the addition of PSS containing 60 mM of KCl, following which concentration-response curves to norepinephrine (NE; A0937; Sigma-Aldrich) were constructed. To assess the effect of free radical scavengers on the obese PVAT, vessels from the obese cohort were incubated with superoxide dismutase (SOD; 100 U/ml; Sigma-Aldrich) and catalase (100 U/ml, Sigma-Aldrich) for 45 min, following which another NE concentration-response curve was constructed. Similarly, vessels were incubated with L-NNA (10-4M, 45 min; Sigma-Aldrich) to assess NO bioavailability within PVAT. When required, removal of the endothelium was performed by a careful brushing technique using a 40-μm-diameter wire (the same as that used for myography) under visualisation by microscopy.
+ Open protocol
+ Expand
8

Quantifying Nitric Oxide Levels in Vessels

Check if the same lab product or an alternative is used in the 5 most similar protocols
For DAF-FM staining, whole-mount cortical sections were incubated in Krebs-Hepes buffer with 20 μM freshly diluted DAF-FM diacetate (Invitrogen, D23844) for 60 min at room temperature. Samples were washed twice with PBS and washed in 0.1% Triton X-100 in PBS for 10 min before imaging. L-NNA (30 mg/kg in saline; Sigma-Aldrich) was administered intraperitoneally 48 and 24 hours before harvest and added during incubation at 1 mg/ml concentration. DAF-FM fluorescence intensity was quantified using ImageJ in three types of vessel segments grouped by their diameter: >60 (large), 35 to 55 (medium), and <30 μm (small). We left a 5-μm gap between the diameter bins to ensure clear separation between them. The L-NNA–sensitive intensity was calculated by subtracting values from L-NNA–treated samples for the same segment. Total nitrite and nitrate (NO3 + NO2) were measured using a commercially available fluorometric nitrite/nitrate assay kit according to the manufacturer’s instructions (Cayman Chemical). The assay is based on nitrite-mediated nitrosation of 2,3-diaminonaphthalene to a fluorescent triazole derivative under acidic conditions. Nitrate anion is reduced to nitrite with the help of nitrate reductase before nitrite measurements.
+ Open protocol
+ Expand
9

Isolated Vessel Experiments with aCSF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated vessel experiments were performed using aCSF (mM): NaCl 122.0, NaHCO3 26.0, KCl 3.0, NaH2PO4 1.25, MgCl2 1.0, CaCl2 2.0, and glucose 4.0. Buffer solutions were made each week and stored without glucose at 4 °C. Glucose was added prior to each experiment. Zero calcium aCSF was made without the addition of CaCl2. U46619, NS309, L-NNA, and SNP were purchased from Sigma (St. Louis, MO, USA). Stock solutions were made weekly and stored at 4° C for L-NNA and SNP. Aliquots of U46619 and NS309 were made and kept frozen at −20° C until use.
+ Open protocol
+ Expand
10

Endothelial Cell Barrier Permeability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HRP‐conjugated anti‐mouse IgG, and rabbit IgG antibodies were purchased from Amersham Biosciences (Heidelberg, Germany); human thrombin from Behring (Marburg, Germany); anti VE‐cadherin (clone TEA 1, mouse IgG) from Beckman Coulter (Krefeld, Germany); ESI‐09 from Biolog (Bremen, Germany); benzonase, forskolin, myristoylated PKI, and Y‐27632, from Calbiochem (Darmstadt, Germany); anti‐phospho‐MLC and anti‐GAPDH antibodies from Cell signaling (Danvers, MA); Rac1 activation assay kit from cytoskeleton (Denver); Pierce® ECL solution from Fischer Scientific (Niederlassung Nidderau, Germany); Alexa‐Flour labelled anti‐mouse IgG and anti‐rabbit IgG antibodies from Invitrogen (Karlsruhe, Germany); anti‐Rac1‐GTP antibody from NewEast Biosciences (King of Prussia, PA); EC basal medium plus supplement pack from PromoCell (Heidelberg, Germany); Complete® protease inhibitor cocktail from Roche (Mannheim, Germany); 3‐isobutyl‐1‐methylxanthine (IBMX), Phalloidin‐TRITC, L‐NAME, L‐NNA, MDL‐12 330A, and anti‐vinculin (clone hVIN‐1, mouse IgG) from Sigma (Steinheim, Germany); anti‐phospho‐MYPT1 (Thr850) from Merck Millipore (Schwalbach, Germany), and Transwell polycarbonate membrane filters (24‐mm round) were from Greiner Bio‐One (Frickenhausen, Germany). All other chemicals were of the best available quality, usually analytical grade.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!